{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T11:14:36Z","timestamp":1758107676935,"version":"3.44.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","injuryjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Injury"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.injury.2021.09.005","type":"journal-article","created":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T17:23:45Z","timestamp":1631467425000},"page":"3206-3216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reversal of direct oral anticoagulants in adult hip fracture patients. A systematic review and meta-analysis"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7320-9556","authenticated-orcid":false,"given":"H.M.F.","family":"Alcock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-580X","authenticated-orcid":false,"given":"S.K.","family":"Nayar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.K.","family":"Moppett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.injury.2021.09.005_bib0001","doi-asserted-by":"crossref","first-page":"d3304","DOI":"10.1136\/bmj.d3304","article-title":"Management of hip fracture in adults: summary of NICE guidance","volume":"342","author":"Ftouh","year":"2011","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.injury.2021.09.005_bib0002","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/archinte.164.20.2260","article-title":"Venous thromboembolism according to age: the impact of an aging population","volume":"164","author":"Stein","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.injury.2021.09.005_bib0003","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2017.12.003","article-title":"Current evidence of oral anticoagulant reversal: A systematic review","volume":"162","author":"Tornkvist","year":"2018","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.injury.2021.09.005_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000279","article-title":"NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis","volume":"3","author":"Hicks","year":"2016","journal-title":"Open Heart"},{"issue":"4","key":"10.1016\/j.injury.2021.09.005_bib0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5694\/mja12.10614","article-title":"Gallus AS. An update of consensus guidelines for warfarin reversal","volume":"198","author":"Tran","year":"2013","journal-title":"Med J Aust"},{"journal-title":"Oral Anticoagulation - Scenario Warfarin","article-title":"National Institute for Health and Care Excellence","year":"2020","key":"10.1016\/j.injury.2021.09.005_bib0006"},{"issue":"2","key":"10.1016\/j.injury.2021.09.005_bib0007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2016.04.042","article-title":"Management of periprocedural anticoagulation: a survey of contemporary practice","volume":"68","author":"Flaker","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"9_suppl","key":"10.1016\/j.injury.2021.09.005_bib0008","doi-asserted-by":"crossref","first-page":"117S","DOI":"10.1177\/1076029618796339","article-title":"The reversal of bleeding caused by new oral anticoagulants (NOACs): A systematic review and meta-analysis","volume":"24","author":"Udayachalerm","year":"2018","journal-title":"Clinical and Applied Thrombosis\/Haemostasis"},{"issue":"3","key":"10.1016\/j.injury.2021.09.005_bib0009","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1120700018759300","article-title":"Implications of anticoagulant and antiplatelet therapy in patients presenting with hip fractures: a current concepts review","volume":"28","author":"Gulati","year":"2018","journal-title":"HIP International"},{"issue":"9","key":"10.1016\/j.injury.2021.09.005_bib0010","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/anae.15008","article-title":"Direct oral anticoagulants and delays to hip fracture repair","volume":"75","author":"Mayor","year":"2020","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1016\/j.injury.2021.09.005_bib0011","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/ACO.0000000000000294","article-title":"Management of direct oral anticoagulants-associated bleeding in the trauma patient","volume":"29","author":"von Heymann","year":"2016","journal-title":"Current Opinion in Anaesthesiology"},{"key":"10.1016\/j.injury.2021.09.005_bib0012","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.jcot.2019.10.004","article-title":"Is anticoagulation reversal necessary prior to surgical treatment of geriatric hip fractures?","volume":"11","author":"Meinig","year":"2020","journal-title":"Journal of Clinical Orthopaedics and Trauma"},{"issue":"10","key":"10.1016\/j.injury.2021.09.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046175","article-title":"Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients","volume":"7","author":"Moja","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.injury.2021.09.005_bib0014","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.injury.2009.01.010","article-title":"Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients","volume":"40","author":"Khan","year":"2009","journal-title":"Injury"},{"issue":"15","key":"10.1016\/j.injury.2021.09.005_bib0015","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1503\/cmaj.092220","article-title":"Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis","volume":"182","author":"Simunovic","year":"2010","journal-title":"Can Med Assoc J"},{"issue":"6","key":"10.1016\/j.injury.2021.09.005_bib0016","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.injury.2015.03.024","article-title":"Is early hip fracture surgery safe for patients on clopidogrel? Systematic review, meta-analysis and meta-regression","volume":"46","author":"Doleman","year":"2015","journal-title":"Injury"},{"issue":"1","key":"10.1016\/j.injury.2021.09.005_bib0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.injury.2021.09.005_bib0018","unstructured":"Electronic Medicines Compendium (eMC). www.medicines.org.uk\/emc\/(accessed 01\/02\/2021)"},{"issue":"4","key":"10.1016\/j.injury.2021.09.005_bib0019","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/bjh.14344","article-title":"British Committee of Standards for Haematology. Peri-operative management of anticoagulation and antiplatelet therapy","volume":"175","author":"Keeling","year":"2016","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.injury.2021.09.005_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/anae.15291","article-title":"S. Guideline for the management of hip fractures 2020: Guideline by the Association of Anaesthetists","volume":"76","author":"Griffiths","year":"2021","journal-title":"Anaesthesia"},{"issue":"7","key":"10.1016\/j.injury.2021.09.005_bib0021","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/trf.14096","article-title":"Efficacy and safety of the drugs used to reverse direct oral anticoagulants: a systematic review and meta-analysis","volume":"57","author":"da Luz","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.injury.2021.09.005_bib0022","unstructured":"The Cochrane Collaboration. Review manager (RevMan) Version 5.3). 2020. https:\/\/training.cochrane.org\/online-learning\/core-software-cochrane-reviews\/revman (accessed 01\/02\/2021)."},{"key":"10.1016\/j.injury.2021.09.005_bib0023","unstructured":"EpiGear International. Metal XL Version 5.3. 2016. https:\/\/www.epigear.com\/index_files\/metaxl.html (accessed 01\/02\/2021)."},{"key":"10.1016\/j.injury.2021.09.005_bib0024","unstructured":"The Cochrane Collaboration. Risk of Bias in Non-randomised studies of Interventions (ROBINS-I). 2020. https:\/\/www.riskofbias.info\/welcome\/home (accessed 01\/02\/2021)."},{"issue":"9","key":"10.1016\/j.injury.2021.09.005_bib0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.injury.2021.09.005_bib0026","unstructured":"The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.10). 2011."},{"key":"10.1016\/j.injury.2021.09.005_bib0027","first-page":"343","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"22","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.injury.2021.09.005_bib0028","unstructured":"National Hip Fracture Database. Best Practice Tariff for Fragility Related Hip Fracture Guide. 2010. https:\/\/www.nhfd.co.uk\/20\/hipfractureR.nsf\/0\/9b0c5ea2e986ff56802577af0046b1df\/%24FILE\/Best%20 Practice%20Tariff%20User%20Guide.pdf (accessed 01\/02\/2021)."},{"issue":"6","key":"10.1016\/j.injury.2021.09.005_bib0029","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.injury.2021.09.005_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/XEB.0000000000000140","article-title":"A generalized pairwise modelling framework for network meta-analysis","volume":"16","author":"Doi","year":"2018","journal-title":"International Journal of Evidence-Based Healthcare"},{"issue":"1","key":"10.1016\/j.injury.2021.09.005_bib0031","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/BOT.0000000000001329","article-title":"Impact of direct oral anticoagulants in patients with hip fractures","volume":"33","author":"Bruckbauer","year":"2019","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.injury.2021.09.005_bib0032","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2019.11.005","article-title":"Delayed time to emergency hip surgery in patients taking oral anticoagulants","volume":"184","author":"Cafaro","year":"2019","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.injury.2021.09.005_bib0033","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/BOT.0000000000001146","article-title":"Outcomes of early surgical intervention in geriatric proximal femur fractures among patients receiving direct oral anticoagulation","volume":"32","author":"Franklin","year":"2018","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.injury.2021.09.005_bib0034","article-title":"New drug, new problem: do hip fracture patients taking NOACs experience delayed surgery, longer hospital stay, or poorer outcomes?","author":"Hourston","year":"2019","journal-title":"HIP International"},{"issue":"3","key":"10.1016\/j.injury.2021.09.005_bib0035","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.3928\/01477447-20190321-02","article-title":"Surgical Delay Is Not Warranted for Patients With Hip Fractures Receiving Non-Warfarin Anticoagulants","volume":"42","author":"Lott","year":"2019","journal-title":"Orthopaedics"},{"issue":"4","key":"10.1016\/j.injury.2021.09.005_bib0036","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020625","article-title":"Should surgery be delayed in patients taking direct oral anticoagulants who suffer a hip fracture? A retrospective, case-controlled observational study at a UK major trauma centre","volume":"8","author":"Mullins","year":"2018","journal-title":"BMJ open"},{"key":"10.1016\/j.injury.2021.09.005_bib0037","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2018.04.022","article-title":"Morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants","volume":"166","author":"Rutenberg","year":"2018","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.injury.2021.09.005_bib0038","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.22374\/cjgim.v13i4.272","article-title":"Emerging barrier to timely care of hip fracture patients: a prospective study of direct oral anticoagulation and time to surgery","volume":"13","author":"Sabo","year":"2018","journal-title":"Canadian Journal of General Internal Medicine"},{"issue":"2","key":"10.1016\/j.injury.2021.09.005_bib0039","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.injury.2018.10.033","article-title":"Safety of urgent hip fracture surgery protocol under influence of direct oral anticoagulation medications","volume":"50","author":"Schermann","year":"2019","journal-title":"Injury"},{"issue":"11","key":"10.1016\/j.injury.2021.09.005_bib0040","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.injury.2019.09.011","article-title":"Impact of oral anticoagulation on proximal femur fractures treated within 24 h\u2013A retrospective chart review","volume":"50","author":"Schuetze","year":"2019","journal-title":"Injury"},{"key":"10.1016\/j.injury.2021.09.005_bib0041","doi-asserted-by":"crossref","DOI":"10.1177\/2151459318764150","article-title":"Use of anticoagulants remains a significant threat to timely hip fracture surgery","volume":"9","author":"Taranu","year":"2018","journal-title":"Geriatric Orthopaedic Surgery & Rehabilitation"},{"issue":"5","key":"10.1016\/j.injury.2021.09.005_bib0042","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.thromres.2015.09.017","article-title":"The impact of oral anticoagulation on time to surgery in patients hospitalized with hip fracture","volume":"136","author":"Tran","year":"2015","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.injury.2021.09.005_bib0043","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40266-018-0609-4","article-title":"Serum concentrations and elimination rates of direct-acting oral anticoagulants (DOACs) in older hip fracture patients hospitalized for surgery: A pilot study","volume":"36","author":"Viktil","year":"2019","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.injury.2021.09.005_bib0044","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-0039-1678718","article-title":"Management of patients taking oral anticoagulants who need urgent surgery for hip fracture","volume":"45","author":"Grandone","year":"2019","journal-title":"Seminars Thrombosis Haemostasis"},{"key":"10.1016\/j.injury.2021.09.005_bib0045","first-page":"1","volume":"8","author":"Klestil","year":"2021"},{"issue":"3","key":"10.1016\/j.injury.2021.09.005_bib0046","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1302\/0301-620X.87B3.15300","article-title":"The effect of hospital type and surgical delay on mortality after surgery for hip fracture","author":"Weller","year":"2005","journal-title":"J Bone Joint Surgery. British volume."},{"key":"10.1016\/j.injury.2021.09.005_bib0047","unstructured":"Fragility Fracture Network. Surgical Principles. https:\/\/www.fragilityfracturenetwork.org\/6-themes-of-the- ffn\/surgical-treatment\/surgical-principles\/(accessed 01\/02\/2021)."},{"issue":"10225","key":"10.1016\/j.injury.2021.09.005_bib0048","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0140-6736(20)30058-1","article-title":"Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial","volume":"395","author":"Borges","year":"2020","journal-title":"Lancet North Am Ed"},{"issue":"12","key":"10.1016\/j.injury.2021.09.005_bib0049","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","article-title":"Andexanet alfa for acute major bleeding associated with factor Xa inhibitors","volume":"375","author":"Connolly","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.injury.2021.09.005_bib0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate","volume":"49","author":"Stangier","year":"2010","journal-title":"Clin Pharmacokinet"}],"container-title":["Injury"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020138321007579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020138321007579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T06:41:16Z","timestamp":1758091276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020138321007579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0020138321007579"],"URL":"https:\/\/doi.org\/10.1016\/j.injury.2021.09.005","relation":{},"ISSN":["0020-1383"],"issn-type":[{"type":"print","value":"0020-1383"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of direct oral anticoagulants in adult hip fracture patients. A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Injury","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.injury.2021.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}